Rexahn Pharmaceuticals, Inc. (RNN:AMEX) Investor Relations Material

Overview

Rexahn Pharmaceuticals is a biopharmaceutical company that is primarily focused on developing treatments for cancer and disorders of the central nervous system. The company is in the early stages of development, and is seeking to discover new drugs to treat these diseases. With a strong focus on research and development, Rexahn Pharmaceuticals is poised to become a leading player in the biopharmaceutical industry.

Annual Reports

Frequently Asked Questions

What is Rexahn Pharmaceuticals, Inc.'s ticker?

Rexahn Pharmaceuticals, Inc.'s ticker is RNN

What exchange is Rexahn Pharmaceuticals, Inc. traded on?

The company's shares trade on the AMEX stock exchange

Where are Rexahn Pharmaceuticals, Inc.'s headquarters?

They are based in Rockville, Maryland

How many employees does Rexahn Pharmaceuticals, Inc. have?

There are 11-50 employees working at Rexahn Pharmaceuticals, Inc.

What is Rexahn Pharmaceuticals, Inc.'s website?

It is http://www.rexahn.com/

What type of sector is Rexahn Pharmaceuticals, Inc.?

Rexahn Pharmaceuticals, Inc. is in the Healthcare sector

What type of industry is Rexahn Pharmaceuticals, Inc.?

Rexahn Pharmaceuticals, Inc. is in the Biotechnology industry

Who are Rexahn Pharmaceuticals, Inc.'s peers and competitors?

The following five companies are Rexahn Pharmaceuticals, Inc.'s industry peers:

- Atreca, Inc.

- Fennec Pharmaceuticals

- Y-mAbs Therapeutics Inc

- CRISPR

- Bellicum Pharmaceuticals Inc